BCC 2023 | De-escalating treatment of patients with breast cancer

Tanja Spanic, PhD, Europa Donna Slovenia, Ljubljana, Slovenia, shares her insights on the current status of de-escalating treatment for patients with breast cancer, delving into the latest research findings and emerging trends in breast cancer treatment and highlighting the challenges and opportunities of de-escalating treatment. Dr Spanic highlights the potential benefit of de-escalation strategies in lower-income countries and mid-income countries, where access to care may be limited. This interview took place at the St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.